Treatment of ANCA – Associated Vasculitis

QR Code

Treatment of ANCA – Associated Vasculitis

None

Saved in:

Bibliographic Details
Main Authors:	Katsiari, Christina G., Sakkas, Lazaros
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/22431
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Proteinase 3 and Neutrophils in ANCA-Associated Systemic Vasculitis
by: Abdgawad, Mohamed
Published: (2011)

The LAMP Story and What It Means for ANCA Positive Vasculitis in Nephrology
by: Rothe, Hansjörg
Published: (2011)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

Treatment of Different Types of Vasculitis
by: Imanishi, Hisayoshi, et al.
Published: (2011)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

Biologic Agents for the Treatment of Systemic Vasculitis
by: Sfriso, P., et al.
Published: (2011)

ANCA Diagnostics in Clinical Practice: New Developments
by: Damoiseaux, Jan, et al.
Published: (2011)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Immunopathogenesis Based Adamantiades- Behcet Disease Vasculitis Treatment
by: Boura, Panagiota, et al.
Published: (2011)

Bypass for the Treatment of Vasculitis Affecting the Central Nervous System
by: Rodríguez-Hernández, Ana, et al.
Published: (2011)

Histopathology of Cutaneous Vasculitis
by: Chen, Ko-Ron
Published: (2011)

Endothelial Cells and Vasculitis
by: Djordjević, Vidosava B., et al.
Published: (2011)

Drug-Induced Vasculitis
by: Radić, Mislav
Published: (2011)

Late-onset neutropenia induced by anti-B cell therapy with rituximab in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2022-06-01)

Starting working meeting on «Russian Register of Patients with ANCA-Associated Systemic Vasculitis» (28 April, 2014, Moscow)
by: Issue Editor
Published: (2014-06-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

Quality of Life Issues in Vasculitis
by: Carpenter, Delesha, et al.
Published: (2011)

Response to Rituximab after Failure of Cyclophosphamide in the Induction Treatment in a Patient with cANCA-associated Vasculitis and Pachymeningitis: a Case Report
by: O. Psenak, et al.
Published: (2021-08-01)

THE VALUE OF THE RUSSIAN NATIONAL REGISTRY OF PATIENTS WITH ANCA-ASSOCIATED SYSTEMIC VASCULITIS AS AN INNOVATIVE TOOL OF PERSONALIZED INDUCTION AND MAINTENANCE THERAPY
by: T. V. Beketova
Published: (2016-12-01)

FDG-PET in Large Vessel Vasculitis
by: Ng, Quinn K.T., et al.
Published: (2011)

Drug Induced Small Vessel Vasculitis
by: Barriga, Jorge Daza, et al.
Published: (2011)

Audiovestibular Manifestations in Systemic Vasculitis: An Update
by: Amor-Dorado, Juan Carlos, et al.
Published: (2011)

Aortitis and aortic aneurysm in systemic vasculitis
by: García-Martínez, Ana, et al.
Published: (2011)

Upper respiratory tract manifestations in patients with ANCA-associated vasculitides and their association with the presence and type of ANCA
by: I. G. Smirnova, et al.
Published: (2021-10-01)

Patients with ANCA-associated vasculitis have low serum thiol levels, and these low levels are correlated with higher disease activity scores
by: Ahmet Kor, et al.
Published: (2025-07-01)